Primo Brands heads into Thursday's Q1 results with analysts broadly constructive but quietly pulling back their price targets — a telling pre-earnings posture for a stock that has quietly recovered 22% year-to-date.
The Street has been trimming, not fleeing. JP Morgan maintained its Overweight on Monday but cut its target from $27 to $26. Barclays did the same in mid-April, shaving from $27 to $24 while keeping its Overweight. Deutsche Bank is the outlier skeptic, holding at Hold with a $19 target — nearly at the current price of $20.09. The consensus mean is $26, implying roughly 30% upside from here, but the direction of travel matters: targets have largely moved in one direction since February. That said, Jefferies upgraded to Buy in late March, suggesting the negative target drift is more about valuation discipline than a structural change in conviction.
The fundamental setup supports the cautious optimism. Forward EPS estimates are well above last year's levels, with the 12-month forward EPS growth percentile ranking at 92 — close to the top of the universe. EV/EBITDA runs at roughly 8.3x on an enterprise value of ~$12.2bn against estimated EBITDA near $1.5bn. Net debt of $4.5bn is the one figure the bears will focus on. That leverage load, combined with $311m in annual interest expense, means free cash flow conversion — not revenue growth — is what the Q1 print needs to demonstrate. Operating cash flow is estimated at $1.1bn annually, making the debt serviceable, but any miss on cash generation will amplify concerns.
Short interest is elevated but not extreme. Around 9.9% of the free float is sold short — a meaningful level — and that position has been building, up roughly 7% over the past month to ~36.6 million shares. Days to cover are 8.2 on the official FINRA count, which means unwinding any short would take time. Borrow costs remain low at 0.45%, and availability is comfortable, so the lending market is not signalling any squeeze pressure. The ORTEX short score of 68 places PRMB in the bottom 5th percentile for short score rank — a reading that points to sustained short interest rather than a building momentum squeeze.
Options positioning is the one angle that reads as genuinely calm. The put/call ratio is running at just 0.15, fractionally below its 20-day average, and well off highs north of 0.5 seen in late March. That is an unusually call-skewed market for a heavily shorted name heading into results. Combined with a flat week in the share price and a 7% one-month gain, options traders are not paying up for downside protection — a stark contrast to the posture seen after the late-April update, which produced a one-day drop of around 4%. The Q1 print will test whether that composure is warranted, or whether debt progress and cash flow momentum can finally move targets back in the other direction.
See the live data behind this article on ORTEX.
Open PRMB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
